Loading organizations...
Loading organizations...
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Jan 12, 2026 | Precede Biosciences | $83.5M Debt / Series B | — | 5AM Ventures, Alexandria Venture Investments, Binney Street Capital, Bristol Myers Squibb, Wouter Meuleman, Labcorp, Lilly Asia Ventures, Mirae Asset Capital, Osage University Partners, Matthias Kleinz |
| Nov 20, 2024 | Valora Therapeutics | $30.0M Seed | Avalon BioVentures, Bregua Corporation, Tiger Gene | — |
| Dec 1, 2021 | NanoMosaic | $41.0M Series A | RA Capital Management | RA Capital, Insight Partners, Pura Vida Investments, John Boyce, Time BioVentures |